Women's Bodies, Women's Wisdom (201 page)

37
. Istfan et al., “An Evaluation of the Nutritional Value of a Soy Protein Concentrate in Young Adult Men Using the Short-Term N-Balance Method”; Wayler et al., “Nitrogen Balance Studies in Young Men to Assess the Protein Quality of an Isolated Soy Protein in Relation to Meat Proteins”; Young et al., “Evaluation of the Protein Quality of an Isolated Soy Protein in Young Men: Relative Nitrogen Requirements and Effects of Methionine Supplementation.”

38
. C. T. Cordle, “Soy Protein Allergy: Incidence and Relative Severity,”
Journal of
Nutrition,
vol. 134, no. 5 (May 2004), pp. 1213S–9S.

39
. Baglieri et al., “Gastro-Jejunal Digestion of Soya-Bean-Milk Protein in Humans.”

40
. M. Cotterchio et al., “Dietary Phytoestrogens Intake Is Associated with Reduced Colorectal Cancer Risk,”
Journal of Nutrition,
vol. 136, no. 12 (Dec. 2006), pp. 3046–53.

41
. H. P. Lee et al., “Dietary Effects on Breast-Cancer Risk in Singapore,”
Lancet,
vol. 337, no. 8751 (May 18, 1991), pp. 1197–200.

42
. A. H. Wu et al., “Tofu and Risk of Breast Cancer in Asian-Americans,”
Cancer Epi-demiology,
Biomarkers and Prevention,
vol. 5, no. 11 (November 1996), pp. 901–6.

43
. S. Yamamoto et al., “Soy, Isoflavones, and Breast Cancer Risk in Japan,”
Journal
of the National Cancer Institute,
vol. 9, no. 12 (June 18, 2003), pp. 906–13.

44
. Council for Responsible Nutrition, “International Researchers Convene Meeting on Isoflavones,” press release, June 17, 2009, available online at
www.npicenter.com/anm/anmviewer.asp?a=24304&print=yes
.

45
. K. Taku et al., “Soy Isoflavones Lower Serum Total and LDL Cholesterol in Humans: A Meta-Analysis of 11 Randomized Controlled Trials,”
American Journal
of Clinical Nutrition,
vol. 85, no. 4 (April 2007), pp. 1148–56.

46
. M. Messina, S. Ho, and D. L. Alekel, “Skeletal Benefits of Soy Isoflavones: A Review of the Clinical Trial and Epidemiologic Data,”
Current Opinion in Clinical
Nutrition and Metabolic Care,
vol. 7, no. 6 (November 2004), pp. 649–58; M. J. Messina, “Legumes and Soybeans: Overview of Their Nutritional Profiles and Health Effects,”
American Journal of Clinical Nutrition,
vol. 70 (Sept. 1999), pp. 439S–50S.

47
. M. Messina and G. Redmond, “Effects of Soy Protein and Soybean Isoflavones on Thyroid Function in Healthy Adults and Hypothyroid Patients: A Review of the Relevant Literature,”
Thyroid,
vol. 16, no. 3 (March 2006), pp. 249–58.

48
. B. Bruce, M. Messina, and G. A. Spiller, “Isoflavone Supplements Do Not Affect Thyroid Function in Iodine-Replete Postmenopausal Women,”
Journal of Medicinal
Food,
vol. 6, no. 4 (Winter 2003), pp. 309–16.

49
. I. C. Munro et al., “Soy Isoflavones: A Safety Review,”
Nutrition Reviews,
vol. 61, no. 1 (Jan. 2003), pp. 1–33; J. Slavin, “Nutritional Benefits of Soy Protein and Soy Fiber,”
Journal of the American Dietetic Association,
vol. 91, no. 7 (July 1991), pp. 816–19.

50
. J. F. Balch,
Prescription for Nutritional Healing
(New York: Avery Publications, 1990).

51
. M. Micallef et al., “Plasma n-3 Polyunsaturated Fatty Acids Are Negatively Associated with Obesity,”
British Journal of Nutrition,
(May 19, 2009), pp. 1–5, [Epub ahead of print].

52
. M. Studer et al., “Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review,”
Archives of Internal Medicine,
vol. 165, no. 7 (April 11, 2005), pp. 725–30.

53
. T. A. Sanders et al., “Influence of n-6 Versus n-3 Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors,”
Arteriosclerosis, Thrombosis, and Vascular Biology,
vol. 17, no. 12 (1997), pp. 3449–60; M. H. Davidson, “Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids,”
American Journal of Cardiology,
vol. 98 (Aug. 21, 2006), pp. 27–33.

54
. A. Leaf and P. C. Weber, “Cardiovascular Effects of N-3 Fatty Acids,”
New England
Journal of Medicine,
vol. 318, no. 9 (March 3, 1988), pp. 549–57; E. B. Schmidt et al., “N-3 Polyunsaturated Fatty Acid Supplementation (Pikasol) in Men with Moderate and Severe Hypertriglyceridaemia: A Dose-Response Study,”
Annals of Nutrition and Metabolism,
vol. 36, no. 5–6 (1992), pp. 283–87; F. B. Hu et al., “Fish and Long-Chain Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women,”
Circulation,
vol. 107, no. 14 (Apr. 15, 2003), pp. 1852–7; P. J. Skerrett and C. H. Hennekens, “Consumption of Fish and Fish Oils and Decreased Risk of Stroke,”
Preventive
Cardiology,
vol. 6, no. 1 (Winter 2003), pp. 38–41; A. Zampelas et al., “Fish Consumption Among Healthy Adults Is Associated with Decreased Levels of Inflammatory Markers Related to Cardiovascular Disease: The ATTICA Study,”
Journal
of the American College of Cardiology,
vol. 46, no. 1 (July 5, 2005), pp. 120–24.

55
. R. L. McLennon, “Reversal of Arrhythmogenic Effects of Long-Term Saturated Fatty Acid Intake by Dietary N3 and N6 Polyunsaturated Fatty Acids,”
American
Journal of Clinical Nutrition,
vol. 51 (1980), pp. 53–58; D. Kim et al., “Dietary Fish Oil Added to Hyperlipidemic Diet for Swine Results in Reduction in Excessive Numbers of Monocytes Attached to Arterial Epithelium,”
Arteriosclerosis,
vol. 81 (1991), pp. 209–16; C. J. Diskin et al., “Fish Oil to Prevent Intimal Hyperplasia and Thrombosis,”
Nephron,
vol. 55 (1990), pp. 445–47.

56
. U. N. Das et al., “Benzo(a)pyrene and Gamma Radiation Induced Genetic Damage in Mice May Be Prevented by GLA but Not Arachidonic Acid,”
Nutrition Research,
vol. 5 (1985), pp. 101–5.

57
. D. Horrobin et al., “Omega-6 Fatty Acids May Reverse Carcinogenesis by Restoring Natural PGE-1 Metabolism,”
Medical Hypotheses,
vol. 6 (1980), pp. 469–86; J. J. Jarkowski and W. T. Cave, “Dietary Fish Oil May Inhibit Development of Breast Cancer,”
Journal of the National Cancer Institute,
vol. 74 (1985), pp. 1145–50.

58
. J. M. Kremer, “N-3 Fatty Acid Supplements in Rheumatoid Arthritis,”
American
Journal of Clinical Nutrition,
vol. 71, no. 1 suppl. (Jan. 2000), pp. 349S–51S; D. Volker et al., “Efficacy of Fish Oil Concentrate in the Treatment of Rheumatoid Arthritis,”
Journal of Rheumatology,
vol. 27, no. 10 (Oct. 2000), pp. 2343–6; C. L. Curtis et al., “Effects of n-3 Fatty Acids on Cartilage Metabolism,”
Proceedings
of the Nutrition Society,
vol. 61, no. 3 (Aug. 2002), pp. 381–89.

59
. D. Parra et al., “A Diet Rich in Long Chain Omega-3 Fatty Acids Modulates Satiety in Overweight and Obese Volunteers During Weight Loss,”
Appetite,
vol. 51, no. 3 (Nov. 2008), pp. 676–80.

60
. R. L. Weank et al., “Effect of Low Saturated Fat Diet in Early and Late Cases of Multiple Sclerosis,”
The Lancet,
vol. 336 (1990), pp. 1145–50.

61
. Z. Harel et al, “Supplementation with Omega-3 Fatty Acids in the Management of Dysmenorrhea in Adolescents,”
American Journal of Obstetrics and Gynecology,
vol. 174, no. 4 (1996), pp. 1335–8.

62
. C. Campagnoli et al., “Polyunsaturated Fatty Acids (PUFAs) Might Reduce Hot Flushes: An Indication from Two Controlled Trials on Soy Isoflavones Alone and with a PUFA Supplement,”
Maturitas,
vol. 51, no. 2 (June 16, 2005), pp. 127–34.

63
. M. Maes et al., “In Humans, Serum Polyunsaturated Fatty Acid Levels Predict the Response of Proinflammatory Cytokines to Psychologic Stress,”
Biological Psychiatry,
vol. 47, no. 10 (May 15, 2000), pp. 910–20.

64
. M. G. Enig et al., “Dietary Fat and Cancer Trends: A Critique,”
Federal Proceedings,
vol. 37 (1978), pp. 25–30.

65
. G. Abraham, “Primary Dysmenorrhea,”
Clinical Obstetrics and Gynecology,
vol. 21, no. 1 (1978), pp. 139–45.

66
. H. G. Preuss et al., “Minimum Inhibitory Concentrations of Herbal Essential Oils and Monolaurin for Gram-Positive and Gram-Negative Bacteria,”
Molecular and
Cellular Biochemistry,
vol. 272, nos. 1–2 (April 2005), pp. 29–34; H. G. Preuss et al., “Effects of Essential Oils and Monolaurin on
Staphylococcus aureus:
In Vitro and In Vivo Studies,”
Toxicology Mechanisms and Methods,
vol. 15, no. 4 (July 2005), pp. 279–85.

67
. D. O. Belluscio and L. E. Ripamonte, “Utility of an Oral Formulation of hCG for Obesity Treatment: A Double-Blind Study,” Oral hCG Research Clinic, available online at
http:www.indexmedico.com/obesity/hcg.htm
; D. O. Belluscio, L. Ripa-monte, and M. Wolansky, “Utility of an Oral Presentation of hCG (Human Chori-ogonadotropin) for the Management of Obesity: A Double-Blind Study,” Oral hCG Research Clinic, available online at
http://hcgobesity.org/hcg_obesity_study.htm
.

68
. J. E. Gangwisch et al., “Inadequate Sleep as a Risk Factor for Obesity: Analyses of the NHANES I,”
Sleep,
vol. 28, no. 10 (October 1, 2005), pp. 1289–96.

69
. B. Villeponteau, R. Cockrell, and J. Feng, “Nutraceutical Interventions May Delay Aging and the Age-Related Diseases,”
Experimental Gerontology,
vol. 35, nos. 9–10 (Dec. 2000), pp. 1405–17.

70
. T. A. Barringer et al., “Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life. A Randomized, Double-Blind, Placebo-Controlled Trial,”
Annals of Internal Medicine,
vol. 138, no. 5 (March 4, 2003), pp. 365–71.

71
. G. Pocobelli et al., “Use of Supplements of Multivitamins, Vitamin C, and Vitamin E in Relation to Mortality,”
American Journal of Epidemiology,
vol. 170, no. 4 (Aug. 15, 2009), pp. 472–83.

72
. E. R. Miller III, “Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality,”
Annals of Internal Medicine,
vol. 142, no. 1 (Jan. 4, 2005), pp. 37–46.

73
. C. D. Morris and S. Carson, “Routine Vitamin Supplementation to Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force,”
Annals of Internal Medicine,
vol. 139, no. 1 (July 1, 2003), pp. 56–70.

74
. M. J. Stampfer et al., “Vitamin E Consumption and the Risk of Coronary Disease in Women,”
New England Journal of Medicine,
vol. 328, no. 20 (May 20, 1993), pp. 1444–9.

75
. R. M. Bostick et al., “Reduced Risk of Colon Cancer with High Intakes of Vitamin E: The Iowa Women’s Health Study,”
Cancer Research,
vol. 53, no. 18 (Sept. 15, 1993), pp. 4230–7.

76
. P. P. Zandi, “Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study.”
Archives of Neurology,
vol. 61, no. 1 (Jan. 2004), pp. 82–88.

77
. M. Lu, “Prospective Study of Dietary Fat and Risk of Cataract Extraction Among U.S. Women,”
American Journal of Epidemiology,
vol. 161, no. 10 (May 15, 2005), pp. 948–59.

78
. J. Higdon,
An Evidence-Based Approach to Vitamins and Minerals
(New York: Thieme, 2003), p. 253; X. Gao et al., “The Maximal Amount of Dietary Alpha-Tocopherol Intake in U.S. Adults (NHANES 2001–2002),”
Journal of Nutrition,
vol. 136 (2006), pp. 1021–6; Q. Jian et al., “Gamma-Tocopherol, the Major Form of Vitamin E in the U.S. Diet, Deserves More Attention,”
American Journal of
Clinical Nutrition,
vol. 74 (2001), pp. 714–22; P. J. McLaughlin and J. L. Weihrauch, “Vitamin E Content of Foods,”
Journal of the American Dietetic Association,
vol. 75 (1979), pp. 647–65; L. C. Nebeling et al., “The Impact of Lifestyle Characteristics on Carotenoid Intake in the United States: The 1987 National Health Interview Survey,”
American Journal of Public Health,
vol. 87 (1997), pp. 268–71; L. C. Nebeling et al., “Changes in Carotenoid Intake in the United States: The 1987 and 1992 National Health Interview Surveys,”
Journal of
the American Dietetic Association,
vol. 97 (1997), pp. 991–96; A. Scalbert and G. Williamson, “Dietary Intake and Bioavailability of Polyphenols,”
Journal of Nutrition,
vol. 130 (2000), pp. 2073S–85S; C. Weber, A. Bysted, and G. Holmer, “Coenzyme Q10 in the Diet—Daily Intake and Relative Bioavailability,”
Molecular
Aspects of Medicine,
vol. 18 (1997), pp. S251–54.

79
. Christiane Northrup,
The Wisdom of Menopause
(New York: Bantam Books, 2001).